Paranoia and Agranulocytosis

Summary:

Agranulocytosis is found among people with Paranoia, especially for people who are female, 60+ old.

The study analyzes which people have Agranulocytosis with Paranoia. It is created by eHealthMe based on reports of 23 people who have Paranoia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Paranoia?

Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur) is found to be associated with 1,041 drugs and 1,276 conditions by eHealthMe. Check the latest studies of Paranoia.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,325 drugs and 3,597 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 27, 2026

23 people who have Paranoia and Agranulocytosis are studied.

Would you have Agranulocytosis when you have Paranoia?

Gender of people who have Paranoia and experienced Agranulocytosis *:

female: 70 %
male: 30 %

Age of people who have Paranoia and experienced Agranulocytosis *:

Common co-existing conditions for these people *:

Aggression: 4 people, 17.39%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 8.70%
Pneumonia: 2 people, 8.70%
Delusion (a false belief or opinion): 2 people, 8.70%
Obsessive Thoughts (intrusive thoughts that produce uneasiness, apprehension, fear, or worry): 2 people, 8.70%
Flatulence (flatus expelled through the anus): 1 person, 4.35%
Agitation (state of anxiety or nervous excitement): 1 person, 4.35%
Compulsions (performing an act persistently and repetitively): 1 person, 4.35%
Constipation: 1 person, 4.35%
Dissociative Disorder: 1 person, 4.35%

Common drugs taken by these people *:

Common symptoms for these people *:

Leukopenia (less number of white blood cells in blood): 8 people, 34.78%
Thrombocytopenia (decrease of platelets in blood): 3 people, 13.04%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 13.04%
Abnormal Behavior: 2 people, 8.70%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 2 people, 8.70%
Haemorrhage (bleeding): 2 people, 8.70%
Impaired Self-Care: 2 people, 8.70%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 8.70%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 2 people, 8.70%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Agranulocytosis?

- Check whether Agranulocytosis is associated with a drug or a condition

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

Related studies:

Treatments, associated drugs and conditions:

Paranoia (23,921 reports)
Agranulocytosis (213,267 reports)

All the drugs that are associated with Agranulocytosis:

Agranulocytosis (2,325 drugs)

All the conditions that are associated with Agranulocytosis:

Agranulocytosis (3,597 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Agranulocytosis and Paranoia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.